Chase AIPricingFAQs
Display currency
Loading news…

Alderley Analytical

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Macclesfield, Cheshire East, United Kingdom Founded 2014 11-50 employees For Profit

Alderley Analyitical is an independent CRO offering specialist bioanalytical services to support your drug development programmes.

Alderley Analytical was acquired by Synexa Life Sciences in 2024.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
43

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
9
Active products
20
IT spend
$224K

Company Info

Founded
2014
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
2
News articles
2
HQ
Macclesfield, Cheshire East, United Kingdom
Region
Europe, Middle East, and Africa (EMEA)
Exit date
Oct 3, 2024

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
1.3
Trend (90d)
-0.1
43
professional contacts at Alderley Analytical
Contact execs at Alderley Analytical

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Alderley Analytical

Loading news…

FAQs about Alderley Analytical

People who checked this page also checked these

Browse the full Acquirezy directory.
Alderley Analytical - Company Profile, Full Acquisitions List, Funding and Investments